These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16696473)

  • 41. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dosimetric consideration of transient volume enlargement induced by edema in prostate brachytherapy seed implants.
    Ali I; Algan O; Thompson S; Sindhwani P; Ahmad S
    Gulf J Oncolog; 2013 Jan; 1(13):6-14. PubMed ID: 23339976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion.
    De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA
    Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of seed migration on post-implant dosimetry of prostate brachytherapy.
    Gao M; Wang JZ; Nag S; Gupta N
    Med Phys; 2007 Feb; 34(2):471-80. PubMed ID: 17388163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
    Melhus CS; Rivard MJ
    Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
    Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy.
    Murphy MK; Piper RK; Greenwood LR; Mitch MG; Lamperti PJ; Seltzer SM; Bales MJ; Phillips MH
    Med Phys; 2004 Jun; 31(6):1529-38. PubMed ID: 15259657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
    Nath R; Meigooni AS; Melillo A
    Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implants.
    Nath R; Roberts K; Ng M; Peschel R; Chen Z
    Med Phys; 1998 Dec; 25(12):2293-307. PubMed ID: 9874821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of post-implant edema on the rectal dose in prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):571-6. PubMed ID: 10524408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brachytherapy dosimetry parameters calculated for a 131Cs source.
    Rivard MJ
    Med Phys; 2007 Feb; 34(2):754-62. PubMed ID: 17388193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants.
    Yue N; Mori J; Nath R; Heron DE; Huq MS
    Phys Med Biol; 2006 May; 51(9):2267-77. PubMed ID: 16625041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Displacement patterns of stranded I-125 seeds after permanent brachytherapy of the prostate: Dosimetry in the operating room put into perspective.
    Steggerda MJ; van den Boom F; Witteveen T; Moonen LMF
    Radiother Oncol; 2017 Jul; 124(1):68-73. PubMed ID: 28633957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist.
    Lessard E; Kwa SL; Pickett B; Roach M; Pouliot J
    Med Phys; 2006 Aug; 33(8):2773-82. PubMed ID: 16964853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosimetric differences between intraoperative and postoperative plans using Cs-131 in transrectal ultrasound-guided brachytherapy for prostatic carcinoma.
    Jones A; Treas J; Yavoich B; Dean D; Danella J; Yumen O
    Med Dosim; 2014; 39(4):286-91. PubMed ID: 25047330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate.
    Kiffer JD; Schumer WA; Mantle CA; McKenzie BJ; Feigen M; Quong GG; Waterman FM
    Australas Radiol; 2003 Jun; 47(2):172-6. PubMed ID: 12780447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.